25 of the Best Oncologists Near Me in greenbrae, CA

Dr. Sima Porten is a specialist in cancers of the genital and urinary organs. She is a member of the urologic oncology team at the UCSF Helen Diller Family Comprehensive Cancer Center. Her clinical interests include the diagnosis and treatment of genitourinary cancer, particularly bladder cancer, upper tract urothelial cancer, kidney cancer and high-risk prostate cancer. Porten's research focuses mainly on the diagnosis and management of urothelial carcinoma, a cancer involving parts of the kidney, bladder and ureter (the tube connecting each kidney to the bladder). In studying the biologic or genetic basis of urothelial carcinoma, she hopes to develop new tests and treatments to bring personalized medicine to patients with bladder cancer. Porten received her undergraduate, medical and master of public health degrees from Northwestern University. During medical school, she was inducted into the Alpha Omega Alpha Honor Medical Society and also completed a fellowship through the Howard Hughes Medical Institute–National Institutes of Health Research Scholars Program. She then completed her urology residency training at UCSF, where she received the Julius R. Krevans Award for Clinical Excellence. During her training in urologic oncology at the University of Texas MD Anderson Cancer Center, she was awarded a John Quale Travel Fellowship for her research in bladder cancer. Porten is an active member of the American Urological Association, American Society of Clinical Oncology, Society of Women in Urology and Society of Urologic Oncology. Dr. Porten is highly rated in 11 conditions, according to our data. Her clinical expertise encompasses Bladder Cancer, Urothelial Cancer, Muscle Invasive Bladder Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Porten is board certified in American Board Of Urology, Urology. Dr. Porten is currently accepting new patients.

Dr. Madhulika (Mika) Varma, chief of colorectal surgery at UCSF Medical Center, specializes in diseases of the colon, rectum and anus. Her areas of expertise include colorectal and anal cancer, inflammatory bowel diseases such as ulcerative colitis and Crohn's disease, and pelvic floor disorders. She also is a specialist in treating many of these diseases using laparoscopic (minimally invasive) surgical techniques. Varma is director of the Center for Pelvic Physiology, which evaluates patients with fecal incontinence, constipation, rectal cancer and anal fistula. She is co-director of the UCSF Center for Inflammatory Bowel Disease and a member of the Women's Continence Center and Women's Health Clinical Research Center. Varma's research interests include clinical outcomes for inflammatory bowel diseases and defecation disorders. Varma earned her medical degree at the Warren Alpert Medical School of Brown University. She completed a residency in general surgery at UCSF and spent a year at the University of Minnesota for specialized training in colon and rectal surgery. In 2000, she returned to UCSF, where she completed a fellowship in clinical outcomes research and epidemiology. Dr. Varma is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Familial Colorectal Cancer, Crohn's Disease, Colorectal Cancer, Hernia Surgery, and Bladder Reconstruction. Dr. Varma is board certified in American Board Of Colon And Rectal Surgery, Colon & Rectal Surgery and American Board Of Surgery, General Surgery. Dr. Varma is currently accepting new patients.

Dr. R. Kate Kelley is a gastrointestinal oncologist who treats liver cancers such as hepatocellular carcinoma; bile duct cancer (cholangiocarcinoma); gastric cancer; esophageal cancer; anal, colon and rectal cancer; pancreatic cancer; and gastrointestinal stromal tumors. Kelley's research interests include developing clinical trials to identify new treatments for gastrointestinal malignancies, particularly hepatocellular carcinoma and bile duct cancer. Kelley graduated from the David Geffen School of Medicine at UCLA and completed a residency at UCLA, where she was chief resident in internal medicine. She also completed a fellowship in hematology and oncology at UCSF. Kelley received the American Society of Clinical Oncology (ASCO) Gastrointestinal Cancers Symposium Merit Award in 2009 and the ASCO Young Investigator Award in 2010. She co-authored a chapter on digestive tract cancers in the textbook Current Medical Diagnosis and Treatment. Dr. Kelley is highly rated in 5 conditions, according to our data. Her clinical expertise encompasses Cholangiocarcinoma (Bile Duct Cancer), Liver Cancer, Fibrolamellar Carcinoma, Gallbladder Cancer, and Tissue Biopsy. Dr. Kelley is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Kelley is currently accepting new patients.

John Chan is an Oncologist and an Obstetrics and Gynecologist practicing medicine in San Francisco, California. Dr. Chan is highly rated in 22 conditions, according to our data. His clinical expertise encompasses Ovarian Cancer, Cervical Cancer, Endometrial Cancer, Oophorectomy, and Hysterectomy. Dr. Chan is board certified in Obstetrics And Gynecology - Board Certified , OB & Gyn (Sub: Gynecologic Oncology), Gynecologic Oncology - Board Certified, and Obstetrics & Gynecology. Dr. Chan is currently accepting new patients.

Dr. Chienying Liu is an endocrinologist who cares for patients with thyroid cancer, thyroid nodules and other thyroid disorders. She also cares for patients with endocrine neoplasia (tumors of hormone producing glands, such as adrenal tumors, pheochromocytomas, paragangliomas, parathyroid tumors, and pituitary tumors). Liu has research interests in thyroid cancer and adrenal disorders. Liu earned her medical degree from the University of Pittsburgh. She completed a residency in internal medicine at the University of Rochester. She completed her fellowship in diabetes, endocrinology and metabolism at UCSF. Liu is a member of the Endocrine Society and American Thyroid Association. She enjoys teaching medical students, residents and fellows. She received the John Karam MD Clinician Educator Award in 2014. In her free time, Liu enjoys active travel and believes that traveling and seeing the world make us better human beings. Dr. Liu is highly rated in 18 conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Papillary Thyroid Cancer, Medullary Thyroid Carcinoma, Thyroidectomy, and Thymectomy. Dr. Liu is board certified in American Board Of Internal Medicine, Endocrinology Diabetes & Metab. Dr. Liu is currently accepting new patients.

Jennifer Lucas is an Oncologist practicing medicine in Greenbrae, California. Dr. Lucas is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Follicular Lymphoma, Non-Hodgkin Lymphoma, Small Lymphocytic Lymphoma (SLL), and Diffuse Large B-Cell Lymphoma (DLBCL).

Bobbie Head is an Oncologist practicing medicine in Greenbrae, California. She has been practicing medicine for over 44 years. Dr. Head is highly rated in 4 conditions, according to our data. Her clinical expertise encompasses Paget Disease of the Breast, Breast Cancer, Inflammatory Breast Cancer, and Angiosarcoma.

Dr. Wei Ai is a blood cancer specialist who cares for adults with conditions such as Hodgkin's lymphoma and non-Hodgkin's lymphoma, including cutaneous lymphomas, which primarily involve the skin. She also sees patients needing blood and bone marrow transplantation. In her research, Ai focuses on novel approaches to lymphoma treatment, especially targeted agents for T-cell lymphomas. Her studies often lead to clinical trials of new therapies that target cancer at the molecular level. Ai earned a doctoral degree in microbiology and immunology as well as her medical degree from Stanford University School of Medicine. She completed a residency in internal medicine at UCSF, followed by fellowship training in medical oncology at Stanford. Dr. Ai is highly rated in 32 conditions, according to our data. Her clinical expertise encompasses Non-Hodgkin Lymphoma, Mycosis Fungoides, Diffuse Large B-Cell Lymphoma (DLBCL), Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Ai is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Ai is currently accepting new patients.

Caring, compassionate, and patient centric care. Dr. Quock is highly rated in 30 conditions, according to our data. His clinical expertise encompasses Small Cell Lung Cancer (SCLC), Thrombocytopenia, Pleuropulmonary Blastoma, Lung Cancer, and Bone Marrow Aspiration. Dr. Quock is board certified in Internal Medicine (Sub: Medical Oncology) and Internal Medicine. Dr. Quock is currently accepting new patients.

Dr. Pamela N. Munster is a medical oncologist who cares for patients with breast cancer. Her roles include director of the early-phase clinical trials program for cancer research; co-director of the UCSF Center for BRCA Research; and co-leader of UCSF's program in developmental therapeutics, which focuses on innovative research to find treatments for advanced cancer. In her own research endeavors, Munster is interested in developing new targeted therapies for treatment-resistant cancer. She studies changes in gene expression and resistance to therapy. Her lab is involved in projects evaluating hormone therapies for breast cancer as well as therapies that engage the immune system to fight tumors. She has published in numerous scientific journals and lectured on topics in breast oncology, such as the management of metastatic breast cancer, breast cancer receptors, clinical trials and translational research (the process of applying study findings to patient care). She has a published memoir, “Twisting Fate: My Journey with BRCA – From Breast Cancer Doctor to Patient and Back.” Munster earned her medical degree from the University of Bern in Switzerland. She completed a residency in internal medicine at Indiana University Health, followed by a fellowship in medical hematology and oncology at Memorial Sloan Kettering Cancer Center, where she also served as faculty in the breast cancer program. Prior to joining UCSF, Munster worked for six years in the Moffitt Cancer Center's division of breast oncology and experimental therapeutics program, serving as scientific director of breast research and co-chair of the phase 1 clinical trial program. Dr. Munster is highly rated in 28 conditions, according to our data. Her clinical expertise encompasses Breast Cancer, HER2 Negative Breast Cancer, BRCA Positive Breast Cancer, Prostatectomy, and Liver Embolization. Dr. Munster is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Munster is currently accepting new patients.

Alan Kramer is an Oncologist practicing medicine in San Francisco, California. Dr. Kramer is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Nasopharyngeal Carcinoma, Angiosarcoma, Paget Disease of the Breast, and Breast Cancer. Dr. Kramer is board certified in Internal Medicine (Sub: Medical Oncology) and Internal Medicine. Dr. Kramer is currently accepting new patients.

Dr. Maxwell Meng is a surgeon specializing in urologic cancers and laparoscopy. His interests in patient care include diagnosing and managing cancers of the genital and urinary organs, as well as minimally invasive treatments of both benign and malignant diseases. He is experienced in robotic surgery. Meng is active in research to develop new treatment technologies. Meng earned his medical degree at Johns Hopkins School of Medicine. He completed general surgery and urology training at UCSF, where he also completed fellowships in urologic oncology and minimally invasive surgery. Dr. Meng is highly rated in 21 conditions, according to our data. His clinical expertise encompasses Bladder Cancer, Renal Cell Carcinoma (RCC), Urothelial Cancer, Nephrectomy, and Reconstructive Urology Surgery. Dr. Meng is board certified in American Board Of Urology, Urology. Dr. Meng is currently accepting new patients.

Kevin Kim is an Oncologist practicing medicine in San Francisco, California. Dr. Kim is highly rated in 17 conditions, according to our data. His clinical expertise encompasses Melanoma, Metastatic Uveal Melanoma, Melanoma of the Eye, and Uveal Melanoma.

Stephanie Jeske is an Oncologist practicing medicine in San Francisco, California. Dr. Jeske is highly rated in 16 conditions, according to our data. Her clinical expertise encompasses Angiosarcoma, Paget Disease of the Breast, Breast Cancer, and Inflammatory Breast Cancer. Dr. Jeske is board certified in Medical Oncology - Board Certified and Hematology - Board Certified. Dr. Jeske is currently accepting new patients.

Dr. Matthew Gubens is a thoracic oncologist who cares for patients with lung cancer. He specializes particularly in treating non-small cell lung cancer, small cell lung cancer, thymoma and thymic carcinoma, and mesothelioma. In his research, Gubens studies new treatment strategies for lung cancer and other malignancies of the chest area. Gubens earned his medical degree at Stanford University School of Medicine. He completed a residency in internal medicine at UCSF and a fellowship in medical oncology at Stanford. He also earned a master's degree in health policy and management at the Harvard T.H. Chan School of Public Health. Gubens is a member of the American Society of Clinical Oncology, International Association for the Study of Lung Cancer and International Thymic Malignancy Interest Group. Dr. Gubens is highly rated in 16 conditions, according to our data. His clinical expertise encompasses Non-Small Cell Lung Cancer (NSCLC), Lung Cancer, Thymic Epithelial Tumor, and Lung Adenocarcinoma. Dr. Gubens is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Gubens is currently accepting new patients.

Dr. Emily Bergsland is a gastrointestinal oncologist at the UCSF Helen Diller Family Comprehensive Cancer Center and the director of the UCSF Center for Neuroendocrine Tumors. She specializes in the multidisciplinary care of patients with neuroendocrine cancers. Bergsland's research is focused on better understanding why neuroendocrine tumors develop, identifying and testing new therapies, and improving outcomes in affected patients. Bergsland earned her medical degree at the University of Minnesota, then completed a residency in internal medicine and fellowship in medical oncology at UCSF. Dr. Bergsland is highly rated in 15 conditions, according to our data. Her clinical expertise encompasses Neuroendocrine Tumor, Carcinoid Syndrome, Pancreatic Islet Cell Tumor, Gastroenteropancreatic Neuroendocrine Tumor (GEP-NET), and Hepatectomy. Dr. Bergsland is board certified in American Board Of Internal Medicine, Medical Oncology. Dr. Bergsland is currently accepting new patients.

Dr. Sanziana Roman is an endocrine surgeon with two decades of experience in treating tumors of the adrenal, thyroid and parathyroid glands. With a particular interest in minimally invasive techniques, she is one of the few surgeons in the world to frequently perform posterior retroperitoneoscopic adrenalectomy, a recently developed way of removing adrenal glands through the back that has advantages over the more common frontal approach. Roman has extensive experience in treating thyroid growths in children and adolescents, as well as in adults. She sees patients with conditions including goiter, Graves' disease, thyroid cancer and congenital hypothyroidism with goiter. She also has expertise in inherited syndromes such as multiple endocrine neoplasia, a group of rare disorders in which the endocrine glands develop tumors. Roman earned her medical degree at Columbia University Vagelos College of Physicians and Surgeons. She completed a residency in general surgery at Yale School of Medicine. Prior to joining UCSF, she was chief of endocrine surgery at Yale for 13 years and later served on the faculty of Duke University for more than five years, becoming a tenured professor of surgery. She was also associate chief of Duke's advanced oncological and gastrointestinal surgery division. She established Duke's centers for adrenal disease and pediatric thyroid disease. Roman has been listed in America's Top Doctors . Her research has been published in numerous medical journals, including JAMA Surgery, Annals of Surgery and Thyroid. She is a fellow of the American College of Surgeons and belongs to the American Association of Endocrine Surgeons, International Association of Endocrine Surgeons, American Thyroid Association, Endocrine Society, Society of University Surgeons and American Surgical Association. Prior to becoming a surgeon, Roman was an opera singer. Her love of singing and surgery have combined into a passion for using her skills to save the voices of patients undergoing neck operations. Dr. Roman is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Hyperparathyroidism, Papillary Thyroid Cancer, Thyroidectomy, and Parathyroidectomy. Dr. Roman is board certified in American Board Of Surgery, General Surgery. Dr. Roman is currently accepting new patients.

Lejla Delic is an Oncologist and an Obstetrics and Gynecologist practicing medicine in San Francisco, California. Dr. Delic is highly rated in 14 conditions, according to our data. Her clinical expertise encompasses Sertoli-Leydig Cell Tumor, Ovarian Carcinosarcoma, Endometrial Cancer, Bladder Reconstruction, and Hysterectomy. Dr. Delic is board certified in Gynecologic Oncology - Board Certified, OB & Gyn (Sub: Gynecologic Oncology), and Obstetrics & Gynecology. Dr. Delic is currently accepting new patients.

Dr. Vadim S. Koshkin is a genitourinary oncologist who specializes in caring for adults with bladder, prostate, kidney and testicular cancers. His personal enthusiasm for travel informs his approach to care, as he likes to hear about where his patients come from in order to better understand who they are. In his research, Koshkin designs and carries out clinical trials of treatments for bladder and prostate cancers. He has a particular focus on the role of immunotherapy, or treatments that stimulate a patient's own immune system to help fight cancer. He also studies targeted treatments that are aimed against specific mutations in the DNA of tumor cells, which make these tumors more vulnerable to particular drugs. This allows for the delivery of personalized treatment based on individual characteristics of patients and their tumors. After earning his medical degree at the University of Chicago Pritzker School of Medicine, Koshkin completed a residency in internal medicine at the University of Michigan. He then completed a fellowship in hematology and oncology at the Cleveland Clinic. He belongs to the American Society of Clinical Oncology, American Association for Cancer Research and Bladder Cancer Advocacy Network. A history and trivia buff, Koshkin loves to read. He also follows soccer and Chicago sports teams in his free time. Dr. Koshkin is highly rated in 14 conditions, according to our data. His clinical expertise encompasses Urothelial Cancer, Bladder Cancer, Renal Cell Carcinoma (RCC), Non-Muscle Invasive Bladder Cancer, and Lymphadenectomy. Dr. Koshkin is board certified in American Board Of Internal Medicine, Medical Oncology and American Board Of Internal Medicine, Internal Medicine. Dr. Koshkin is currently accepting new patients.

Gauri Kelekar is an Oncologist practicing medicine in San Francisco, California. She has been practicing medicine for over 18 years. Dr. Kelekar is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Familial Pancreatic Cancer, Familial Colorectal Cancer, Urothelial Cancer, and Fibrolamellar Carcinoma. Dr. Kelekar is board certified in Medical Oncology - Internal Medicine Hematology. Dr. Kelekar is currently accepting new patients.

Dr. Julie Ann Sosa is an endocrine surgeon who specializes in thyroid cancer. She also has expertise in treating adults and children for a variety of benign and malignant endocrine conditions of the thyroid, parathyroid and adrenal glands. She chairs the UCSF Department of Surgery. Sosa's research focuses on developing treatments for advanced thyroid cancer and understanding environmental factors that can raise a person's risk for the disease. She also has published extensively on predictors of optimal patient outcomes following a variety of cancer-based procedures. Sosa earned her medical degree at Johns Hopkins University School of Medicine, where she also completed the Halsted residency in general surgery and served as chief resident. She completed a fellowship in clinical research with the Robert Wood Johnson Foundation at Johns Hopkins, where she was also assistant chief of service and an instructor. She has a master's degree in human sciences from the University of Oxford. Prior to joining UCSF, she was chief of endocrine surgery at Duke University, and held leadership positions at the Duke Cancer Institute and Duke Clinical Research Institute. Sosa is a fellow of the American College of Surgeons. She is the elected editor-in-chief of the World Journal of Surgery, and had previous positions as deputy editor of JAMA Surgery and associate editor of the Journal of Surgical Research. She serves on the editorial boards of seven medical journals, including the Annals of Surgery, Surgery, Annals of Surgical Oncology, Endocrine and International Journal of Endocrine Oncology. She serves on the boards of the Society of Surgical Oncology, International Thyroid Oncology Group, Association for Academic Surgery Foundation and American Thyroid Association, where she is also treasurer. She is the Leon Goldman, MD Distinguished Professor of Surgery at UCSF. Sosa was born in Montréal and raised in upstate New York. Dr. Sosa is highly rated in 12 conditions, according to our data. Her clinical expertise encompasses Thyroid Cancer, Papillary Thyroid Cancer, Parathyroid Cancer, Thyroidectomy, and Parathyroidectomy. Dr. Sosa is board certified in American Board Of Surgery, General Surgery. Dr. Sosa is currently accepting new patients.

Dr. Collin Blakely is a medical oncologist who specializes in lung cancer. In addition to treating patients, he conducts research focused on understanding the cellular and molecular mechanisms underlying lung cancer resistance to targeted therapies. His goal is to translate laboratory findings into new treatments. Blakely received his bachelor's degree in molecular and cellular biology from the University of Washington. He attended the Medical Scientist Training Program at the Perelman School of Medicine, earning both his medical and doctoral degrees. He completed his fellowship training in medical oncology at UCSF. Dr. Blakely is highly rated in 11 conditions, according to our data. His clinical expertise encompasses Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Lung Adenocarcinoma. Dr. Blakely is board certified in American Board Of Internal Med/Medical Oncology, Medical Oncology. Dr. Blakely is currently accepting new patients.

Dr. Alfred Chung is a hematologist-oncologist who cares for patients with blood cancers, including leukemias, lymphomas and myelomas. He sees patients who are in the hospital for treatment, including those who need a bone marrow transplant and those receiving chemotherapy or cellular therapies to bolster the immune system. Chung's research centers on the study and development of new therapies for plasma cell disorders, including multiple myeloma and amyloidosis (buildup of an abnormal protein called amyloid in the organs). One specific area of study is light chain amyloidosis, in which the dysfunction of certain antibody-producing cells results in abnormal protein fibers in the organs. Chung is looking specifically at targeted therapies to treat this type of amyloidosis as well as novel therapeutic strategies in the treatment of multiple myeloma. After earning a bachelor's degree in chemical engineering at the University of Michigan, Chung earned a medical degree at Northwestern University Feinberg School of Medicine. At Stanford Medicine, he completed a residency in internal medicine, followed by a fellowship in hematology and oncology. Chung is a member of the American Society of Clinical Oncology, American Society of Hematology and Association of Northern California Oncologists. Dr. Chung is highly rated in 10 conditions, according to our data. His clinical expertise encompasses Multiple Myeloma, Relapsed Refractory Multiple Myeloma (RRMM), Smoldering Multiple Myeloma, Bone Marrow Transplant, and Bone Marrow Aspiration. Dr. Chung is board certified in American Board Of Internal Medicine/Hematology, Hematology, American Board Of Internal Medicine, Medical Oncology, and American Board Of Internal Medicine, Internal Medicine. Dr. Chung is currently accepting new patients.

Dr. Jennifer Perkins is an endocrinologist who specializes in endocrine neoplasia (tumors of hormone-producing glands, such as adrenal, thyroid and parathyroid tumors) with a focus in thyroid cancers and familial adrenal tumors. As co-director of UCSF's endocrine neoplasia program, she works with surgeons, radiation oncologists, medical oncologists and other endocrinologists to care for her patients. Perkins earned her medical degree at the Geisel School of Medicine at Dartmouth. She completed a residency in internal medicine at Virginia Commonwealth University Health and a fellowship in endocrinology at Vanderbilt University Medical Center. After completing her medical studies, she earned a master's degree in business administration at Duke University's Fuqua School of Business. Perkins has received numerous teaching awards and published many book chapters and articles on topics related to endocrine neoplasia. Dr. Perkins is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Anaplastic Thyroid Cancer, Follicular Thyroid Cancer, Thyroid Cancer, and Medullary Thyroid Carcinoma. Dr. Perkins is board certified in American Board Of Internal Medicine, Endocrinology Diabetes & Metab and American Board Of Internal Medicine, Internal Medicine. Dr. Perkins is currently accepting new patients.

Dr. Peter Carroll is a surgeon specializing in urological oncology. He is internationally known for his expertise in managing patients with cancers of the urinary system. In research, Carroll's areas of interest include early detection and patient-centered management of urological cancers, most notably prostate cancer. He is principal investigator or co-investigator of many studies that received peer-reviewed research grants as well as author or co-author of more than 700 publications. Carroll earned his medical degree from Georgetown University School of Medicine, graduating with honors. He completed training in general surgery and a residency in urology at UCSF. He completed a fellowship in urologic oncology at Memorial Sloan Kettering Cancer Center before returning to UCSF. He also has a master of public health degree from the University of California, Berkeley. At UCSF, he holds both the Ken and Donna Derr-Chevron and Taube Family distinguished professorships. Dr. Carroll is highly rated in 9 conditions, according to our data. His clinical expertise encompasses Prostate Cancer, Familial Prostate Cancer, Bladder Cancer, Prostatectomy, and Reconstructive Urology Surgery. Dr. Carroll is board certified in American Board Of Urology, Urology. Dr. Carroll is currently accepting new patients.